Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Varian Medical Systems Inc (VAR) since 2014 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Varian Medical Systems Inc. (See page 1 of this report.) Table 2 shows the detailed insider transactions. This company's CIK number is 203527.
Total stock buying since 2014: $0.
Total stock sales since 2014: $266,070,765.
Total stock option exercises since 2014: $157,814,248.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2021 | 0 | $0 | 6,499 | $1,142,563 | 20,479 | $0 |
| 2020 | 0 | $0 | 498,458 | $83,257,022 | 640,772 | $52,794,293 |
| 2019 | 0 | $0 | 201,694 | $27,201,462 | 227,786 | $15,753,493 |
| 2018 | 0 | $0 | 129,027 | $15,251,882 | 146,025 | $7,063,404 |
| 2017 | 0 | $0 | 336,008 | $34,394,204 | 364,662 | $19,245,511 |
| 2016 | 0 | $0 | 238,214 | $21,445,204 | 257,921 | $12,920,829 |
| 2015 | 0 | $0 | 517,247 | $46,285,355 | 540,855 | $26,903,815 |
| 2014 | 0 | $0 | 440,565 | $37,093,073 | 479,425 | $23,132,903 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2015-02-17 | Kuo John W (SVP, Gen Counsel and Secretary) | Option Ex | 1,792 | .00 | 0 |
| 2015-02-17 | Wilson Dow R (President and CEO) | Option Ex | 5,973 | .00 | 0 |
| 2015-02-17 | Finney Elisha W (Exec VP and CFO) | Option Ex | 2,124 | .00 | 0 |
| 2015-02-10 | Thyagarajan Venkatraman (Director) | Option Ex | 1,545 | .00 | 0 |
| 2015-02-10 | Laret Mark R (Director) | Sale | 10,000 | 92.32 | 923,160 |
| 2015-02-10 | Laret Mark R (Director) | Option Ex | 11,545 | 28.25 | 326,146 |
| 2015-02-10 | Naumann-etienne Ruediger (Director) | Option Ex | 1,545 | .00 | 0 |
| 2015-02-10 | Eckert R Andrew (Director) | Option Ex | 1,545 | .00 | 0 |
| 2015-02-10 | Bostrom Susan L (Director) | Option Ex | 1,545 | .00 | 0 |
| 2015-02-10 | Illingworth David J (Director) | Option Ex | 1,545 | .00 | 0 |
| 2015-02-09 | Kuo John W (SVP, Gen Counsel and Secretary) | Sale | 582 | 92.80 | 54,008 |
| 2015-02-09 | Kuo John W (SVP, Gen Counsel and Secretary) | Option Ex | 582 | 68.84 | 40,064 |
| 2015-02-03 | Thyagarajan Venkatraman (Director) | Sale | 10,000 | 92.71 | 927,120 |
| 2015-02-03 | Thyagarajan Venkatraman (Director) | Option Ex | 10,000 | 70.48 | 704,800 |
| 2015-02-02 | Kuo John W (SVP, Gen Counsel and Secretary) | Sale | 3,490 | 92.46 | 322,685 |
| 2015-02-02 | Kuo John W (SVP, Gen Counsel and Secretary) | Option Ex | 3,490 | 68.84 | 240,251 |
| 2015-02-02 | Wilson Dow R (President and CEO) | Sale | 60,000 | 92.39 | 5,543,580 |
| 2015-02-02 | Wilson Dow R (President and CEO) | Option Ex | 60,000 | 49.88 | 2,992,800 |
| 2015-02-02 | Naumann-etienne Ruediger (Director) | Sale | 10,000 | 91.87 | 918,730 |
| 2015-02-02 | Naumann-etienne Ruediger (Director) | Option Ex | 10,000 | 70.48 | 704,800 |
| 2015-02-02 | Guertin Timothy E (Director) | Sale | 50,000 | 92.05 | 4,602,500 |
| 2015-02-02 | Guertin Timothy E (Director) | Option Ex | 50,000 | 52.83 | 2,641,500 |
| 2015-02-02 | Finney Elisha W (Exec VP and CFO) | Sale | 6,667 | 92.23 | 614,924 |
| 2015-02-02 | Finney Elisha W (Exec VP and CFO) | Option Ex | 6,667 | 52.83 | 352,217 |
| 2015-01-05 | Guertin Timothy E (Director) | Sale | 50,000 | 86.30 | 4,315,200 |
| 2015-01-05 | Guertin Timothy E (Director) | Option Ex | 50,000 | 52.83 | 2,641,500 |
| 2015-01-02 | Finney Elisha W (Exec VP and CFO) | Sale | 15,000 | 87.23 | 1,308,450 |
| 2015-01-02 | Finney Elisha W (Exec VP and CFO) | Option Ex | 15,000 | 52.83 | 792,450 |
| 2014-12-11 | Guertin Timothy E (Director) | Sale | 105,000 | 86.67 | 9,100,350 |
| 2014-12-11 | Guertin Timothy E (Director) | Option Ex | 105,000 | 52.72 | 5,535,600 |
| 2014-12-09 | Kennedy Kolleen T (SVP and Pres. Oncology Sys.) | Sale | 725 | 88.04 | 63,827 |
| 2014-12-09 | Kennedy Kolleen T (SVP and Pres. Oncology Sys.) | Option Ex | 775 | 68.84 | 53,351 |
| 2014-12-01 | Finney Elisha W (Exec VP and CFO) | Sale | 21,000 | 88.49 | 1,858,269 |
| 2014-12-01 | Finney Elisha W (Exec VP and CFO) | Option Ex | 21,000 | 51.74 | 1,086,645 |
| 2014-11-24 | Finney Elisha W (Exec VP and CFO) | Sale | 2,930 | 88.24 | 258,531 |
| 2014-11-21 | Verhoef Clarence R (SVP, Finance, Corp Controller) | Option Ex | 3,173 | .00 | 0 |
| 2014-11-21 | Kennedy Kolleen T (SVP and Pres. Oncology Sys.) | Option Ex | 4,920 | .00 | 0 |
| 2014-11-21 | Kuo John W (SVP, Gen Counsel and Secretary) | Option Ex | 4,148 | .00 | 0 |
| 2014-11-21 | Wilson Dow R (President and CEO) | Option Ex | 12,666 | .00 | 0 |
| 2014-11-21 | Guertin Timothy E (Director) | Option Ex | 10,139 | .00 | 0 |
| 2014-11-21 | Finney Elisha W (Exec VP and CFO) | Option Ex | 6,124 | .00 | 0 |
| 2014-11-17 | Finney Elisha W (Exec VP and CFO) | Sale | 1,837 | 87.71 | 161,123 |
| 2014-11-11 | Kennedy Kolleen T (SVP and Pres. Oncology Sys.) | Sale | 533 | 86.66 | 46,190 |
| 2014-11-11 | Kennedy Kolleen T (SVP and Pres. Oncology Sys.) | Option Ex | 641 | 57.90 | 37,113 |
| 2014-11-11 | Kuo John W (SVP, Gen Counsel and Secretary) | Sale | 606 | 86.63 | 52,499 |
| 2014-11-11 | Kuo John W (SVP, Gen Counsel and Secretary) | Option Ex | 606 | 57.90 | 35,087 |
| 2014-11-10 | Kennedy Kolleen T (SVP and Pres. Oncology Sys.) | Sale | 709 | 85.13 | 60,360 |
| 2014-11-10 | Kennedy Kolleen T (SVP and Pres. Oncology Sys.) | Option Ex | 776 | 68.84 | 53,419 |
| 2014-11-10 | Naumann-etienne Ruediger (Director) | Sale | 5,000 | 85.31 | 426,535 |
| 2014-11-10 | Naumann-etienne Ruediger (Director) | Option Ex | 5,000 | 64.73 | 323,650 |
| 2014-11-10 | Eckert R Andrew (Director) | Sale | 5,000 | 85.11 | 425,530 |
| 2014-11-10 | Eckert R Andrew (Director) | Option Ex | 5,000 | 52.61 | 263,050 |
| 2014-11-03 | Guertin Timothy E (Director) | Sale | 80,000 | 83.69 | 6,695,280 |
| 2014-11-03 | Guertin Timothy E (Director) | Option Ex | 80,000 | 52.61 | 4,208,800 |
| 2014-11-03 | Finney Elisha W (Exec VP and CFO) | Sale | 25,000 | 83.91 | 2,097,800 |
| 2014-11-03 | Finney Elisha W (Exec VP and CFO) | Option Ex | 25,000 | 51.74 | 1,293,625 |
| 2014-10-29 | Finney Elisha W (Exec VP and CFO) | Sale | 10,000 | 83.95 | 839,500 |
| 2014-10-29 | Finney Elisha W (Exec VP and CFO) | Option Ex | 10,000 | 52.83 | 528,300 |
| 2014-10-27 | Kennedy Kolleen T (SVP and Pres. Oncology Sys.) | Sale | 1,240 | 81.00 | 100,440 |
| 2014-10-27 | Kennedy Kolleen T (SVP and Pres. Oncology Sys.) | Option Ex | 1,415 | 63.37 | 89,668 |
| 2014-10-13 | Kuo John W (SVP, Gen Counsel and Secretary) | Sale | 606 | 79.64 | 48,262 |
| 2014-10-13 | Kuo John W (SVP, Gen Counsel and Secretary) | Option Ex | 606 | 57.90 | 35,087 |
| 2014-10-01 | Finney Elisha W (Exec VP and CFO) | Sale | 15,000 | 79.98 | 1,199,700 |
| 2014-10-01 | Finney Elisha W (Exec VP and CFO) | Option Ex | 15,000 | 50.66 | 759,900 |
| 2014-09-11 | Kennedy Kolleen T (SVP and Pres. Oncology Sys.) | Option Ex | 641 | 57.90 | 37,113 |
| 2014-09-11 | Kuo John W (SVP, Gen Counsel and Secretary) | Sale | 605 | 85.82 | 51,923 |
| 2014-09-11 | Kuo John W (SVP, Gen Counsel and Secretary) | Option Ex | 605 | 57.90 | 35,029 |
| 2014-09-09 | Kennedy Kolleen T (SVP and Pres. Oncology Sys.) | Option Ex | 776 | 68.84 | 53,419 |
| 2014-09-02 | Finney Elisha W (Exec VP and CFO) | Sale | 20,000 | 85.18 | 1,703,600 |
| 2014-09-02 | Finney Elisha W (Exec VP and CFO) | Option Ex | 20,000 | 51.74 | 1,034,900 |
| 2014-08-20 | Thyagarajan Venkatraman (Director) | Sale | 5,000 | 84.25 | 421,250 |
| 2014-08-20 | Thyagarajan Venkatraman (Director) | Option Ex | 5,000 | 64.73 | 323,650 |
| 2014-08-11 | Kennedy Kolleen T (SVP and Pres. Oncology Sys.) | Sale | 776 | 85.03 | 65,984 |
| 2014-08-11 | Kennedy Kolleen T (SVP and Pres. Oncology Sys.) | Option Ex | 1,416 | 63.37 | 89,731 |
| 2014-08-11 | Kuo John W (SVP, Gen Counsel and Secretary) | Sale | 606 | 85.07 | 51,549 |
| 2014-08-11 | Kuo John W (SVP, Gen Counsel and Secretary) | Option Ex | 606 | 57.90 | 35,087 |
| 2014-08-07 | Finney Elisha W (Exec VP and CFO) | Sale | 5,000 | 83.95 | 419,750 |
| 2014-08-07 | Finney Elisha W (Exec VP and CFO) | Option Ex | 5,000 | 52.83 | 264,150 |
| 2014-08-01 | Guertin Timothy E (Director) | Sale | 80,000 | 81.48 | 6,518,720 |
| 2014-08-01 | Guertin Timothy E (Director) | Option Ex | 80,000 | 52.61 | 4,208,800 |
| 2014-08-01 | Finney Elisha W (Exec VP and CFO) | Sale | 15,000 | 81.58 | 1,223,670 |
| 2014-08-01 | Finney Elisha W (Exec VP and CFO) | Option Ex | 15,000 | 50.66 | 759,900 |
| 2014-07-14 | Kennedy Kolleen T (SVP and Pres. Oncology Sys.) | Sale | 641 | 85.12 | 54,564 |
| 2014-07-14 | Kennedy Kolleen T (SVP and Pres. Oncology Sys.) | Option Ex | 641 | 57.90 | 37,113 |
| 2014-07-11 | Kuo John W (SVP, Gen Counsel and Secretary) | Sale | 605 | 84.96 | 51,399 |
| 2014-07-11 | Kuo John W (SVP, Gen Counsel and Secretary) | Option Ex | 605 | 57.90 | 35,029 |
| 2014-07-09 | Kennedy Kolleen T (SVP and Pres. Oncology Sys.) | Sale | 775 | 84.69 | 65,632 |
| 2014-07-09 | Kennedy Kolleen T (SVP and Pres. Oncology Sys.) | Option Ex | 775 | 68.84 | 53,351 |
| 2014-07-09 | Kuo John W (SVP, Gen Counsel and Secretary) | Sale | 582 | 85.00 | 49,470 |
| 2014-07-09 | Kuo John W (SVP, Gen Counsel and Secretary) | Option Ex | 582 | 68.84 | 40,064 |
| 2014-07-01 | Finney Elisha W (Exec VP and CFO) | Sale | 20,000 | 83.89 | 1,677,820 |
| 2014-07-01 | Finney Elisha W (Exec VP and CFO) | Option Ex | 20,000 | 51.74 | 1,034,900 |
| 2014-06-23 | Kuo John W (SVP, Gen Counsel and Secretary) | Sale | 1,745 | 85.00 | 148,325 |
| 2014-06-23 | Kuo John W (SVP, Gen Counsel and Secretary) | Option Ex | 1,745 | 68.84 | 120,125 |
| 2014-06-16 | Kennedy Kolleen T (SVP and Pres. Oncology Sys.) | Sale | 1,416 | 82.42 | 116,703 |
| 2014-06-16 | Kennedy Kolleen T (SVP and Pres. Oncology Sys.) | Option Ex | 1,416 | .00 | 0 |
| 2014-06-11 | Kuo John W (SVP, Gen Counsel and Secretary) | Sale | 606 | 81.38 | 49,313 |
| 2014-06-11 | Kuo John W (SVP, Gen Counsel and Secretary) | Option Ex | 606 | 57.90 | 35,087 |
| 2014-06-02 | Finney Elisha W (Exec VP and CFO) | Sale | 10,000 | 82.35 | 823,500 |
| 2014-06-02 | Finney Elisha W (Exec VP and CFO) | Option Ex | 10,000 | 50.66 | 506,599 |
| 2014-05-12 | Kennedy Kolleen T (SVP and Pres. Oncology Sys.) | Sale | 641 | 82.39 | 52,811 |
| 2014-05-12 | Kennedy Kolleen T (SVP and Pres. Oncology Sys.) | Option Ex | 641 | 57.90 | 37,113 |
| 2014-05-12 | Kuo John W (SVP, Gen Counsel and Secretary) | Sale | 605 | 82.38 | 49,839 |
| 2014-05-12 | Kuo John W (SVP, Gen Counsel and Secretary) | Option Ex | 605 | 57.90 | 35,029 |
| 2014-05-09 | Kennedy Kolleen T (SVP and Pres. Oncology Sys.) | Sale | 776 | 81.26 | 63,055 |
| 2014-05-09 | Kennedy Kolleen T (SVP and Pres. Oncology Sys.) | Option Ex | 776 | 68.84 | 53,419 |
Insider trading activities including stock purchases, stock sales, and option exercises of VAR listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Varian Medical Systems Inc (symbol VAR, CIK number 203527) see the Securities and Exchange Commission (SEC) website.